Vascular Diseases Clinical Trial
Official title:
Comparison Between Two Mathematical Methods to Estimate Arterial Occlusion Pressure and Tourniquet Effectiveness in Lower Limb Surgery: Randomized Comparative Study
Pneumatic tourniquets are widely used not only to reduce blood loss and to ensure optimal operating conditions during extremity surgery, but also in regional anesthesia (local intravenous) vein puncture and to control life or limb threatening conditions. However, compression of the tissues under a tourniquet is associated with soft tissue damage involving the skin, vessels, muscles, and most importantly, nerves, and are commonly pressure related and can be affected by tourniquet time as well. Therefore, the "minimal tourniquet inflation pressure" necessary to provide a bloodless field has been suggested to minimize the risk of complications from excessive inflation pressure. Arterial occlusion pressure (AOP) is the lowest pneumatic tourniquet inflation pressure required to stop the arterial blood flow into the limb, and its usage has been shown to be useful in optimizing tourniquet cuff pressures. The pressure to which a pneumatic tourniquet cuff should be inflated depends on a number of variables, including the patient's age, skin, blood pressure and the shape and size of the extremity in question, as well as the dimensions of the cuff. One of the estimation method for AOP is based on systolic blood pressure (SBP) and tissue padding coefficient (KTP) values (AOP=[SBP+10]/KTP) according to extremity circumferences. Unver B. et al., used this method to estimate effective tourniquet pressure in total knee replacement under hypotensive general anesthesia tourniquet pressure achieved was 169.7±7.9 mmHg, while Tuncali et al., tested it again in different lower limb surgeries under general or neuraxial anesthesia with normotensive techniques and the achieved maximal tourniquet pressures used was 173.3±15.6 mmHg. Hong-yun Liu et al., established a new occlusion pressure mathematical model for the upper limb based on the correlation analysis between several possible influencing parameters and the minimal pneumatic tourniquet pressure.
After ethical committee approval and informed consent from the patients, 80 adult patients
18-40 years old, (ASA I-II), scheduled for knee arthroscopy under general anesthesia with
pneumatic tourniquet around the thigh, will be randomly allocated (using closed opaque
envelop) into one of two groups:
- Group (A): where the pneumatic tourniquet inflated 20 mmHg above the arterial occlusion
pressure which will be estimated using the equation of Unver B. et al., [1]:
(AOP=[SBP+10]/KTP)
- Group (B): where the pneumatic tourniquet inflated 20 mmHg above the arterial occlusion
pressure which will be estimated using the equation of Hong-yun Liu et al., [2]: (AOP =
17.986 + 3.158X1 + 0.408X2) Patients will be excluded from the study if they are outside
the age range, hypertensive, diabetic, complaining of any lower limb claudications, any
vascular disease, hemolytic blood disorders or hypercoagulability.
Upon arrival to the operating room, standard monitoring will be attached (5 lead ECG, pulse
oximeter and non-invasive blood pressure) followed by a wide-bore canula will be inserted a
big vein in the upper limb. General anesthesia will be induced using fentanyl 1 mcg/kg and
propofol 2-3 mg/kg laryngeal mask airway device will be inserted after atracurium 0.5 mg/kg
and lungs will be mechanically ventilated to maintain end-tidal CO2 at 36-40 mmHg and
maintenance of anesthesia will be achieved using isoflurane 1-2 volume %. Hemodynamic
stabilization will be assured and systolic blood pressure will be maintained within the
pre-induction values ± 20% using intravenous fluid infusion and titration of inhalational
anesthetics.
In all patients, the thigh circumference will be measured 20 cm proximal to the superior pole
of the patella then, pneumatic the tourniquet cuff will be placed (deflated) around the thigh
with the distal edge 15 cm proximal to the proximal pole of the patella. The tissue padding
coefficients based on limb circumferences will be calculated in all patients of group (A)
according to table (1) [3].
After three successive stable systolic blood pressure reading (5 minutes apart), an initial
systolic blood pressure [initial SBP] reading will take and estimated arterial occlusion
pressure (AOP) will be quickly calculated according to one of the previously mentioned
equation followed limb exsanguination using an Esmarch bandage, then the tourniquet cuff will
be inflated to a safety margin pressure 20 mmHg above the calculated (AOP) [3] which will be
the [initial tourniquet pressure]. The time between the initial SBP taking and tourniquet
inflation will be measured [initial SBP-to- tourniquet inflation time]. The absence of
arterial flow in the lower limb is assured using Doppler probe (HD, Philips) positioned, by
an independent anesthetist, at either the dorsalis pedis artery or the posterior tibial
artery on the foot to monitor arterial flow distal to the tourniquet. If any arterial flow
sound will be heard, the estimated tourniquet pressure will be considered insufficient and
the patient will excluded from the study. When no arterial blood flow is secured, the surgeon
(blinded to the groups) will allowed to start and will be asked to rate the bloodless
surgical field using a 4-point scale [1 (Excellent) = No blood in the surgical field, 2
(Good) = Some blood in the surgical field but no interference with surgery, 3 (Fair) = Blood
in the surgical field but no significant interference with surgery, 4 (Poor) = Blood in the
surgical field obscures the view] [3] at the beginning, in the middle, and at the end of the
surgical procedure.
During the surgery, systolic blood pressure will be measured every 5 minutes and the
tourniquet inflation pressure will be always kept 20 mmHg above the SBP.
Surgical procedure and anesthetic management were performed by the same surgical and
anesthesia teams respectively. The attending anesthesiologist was aware of the allocated
group, but the data analyst, surgeon and the patients were blinded to group allocation.
All the patients will be examined one day after surgery for any complications associated with
the tourniquet, (e.g. tissue damage, nerve palsy, lower limb blood flow).
The following will be measured:
- Patient's age, weight and gender and lower limb circumference?
- Operative duration and tourniquet time.
- Initial SBP-to- tourniquet inflation time
- Primary outcome: initial and maximal SBP, initial and maximum tourniquet inflation
pressure.
- Secondary outcome: surgeon rating of the bloodlessness of the surgical field.
- Any tourniquet associated complications.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05971407 -
The Effect of Chronic Remote Ischaemic Preconditioning on Blood Pressure in Older Adults
|
N/A | |
| Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
| Recruiting |
NCT04390672 -
Multivessel TALENT
|
N/A | |
| Recruiting |
NCT04584632 -
The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery
|
N/A | |
| Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
| Completed |
NCT01684826 -
X-ray Dose Reduction Study for Cardiac Angiography and Intervention
|
N/A | |
| Completed |
NCT01417910 -
Predictors of Post Operative Outcome in Peripheral Vascular Surgical Patients
|
N/A | |
| Terminated |
NCT00935766 -
Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
|
Phase 3 | |
| Unknown status |
NCT01748383 -
The Long-term and Short-term Efficacy and Safety of Transplantation Autologous Bone Marrow Cells (BMCs) in Patients With the First STEMI (ST Segment Elevation Myocardial Infarction)
|
Phase 2 | |
| Recruiting |
NCT05907564 -
Aventus Thrombectomy System Pulmonary Embolism Clinical Study
|
N/A | |
| Recruiting |
NCT03732612 -
Inflammation in Vascular Disease
|
||
| Completed |
NCT00000614 -
Prevention of Recurrent Venous Thromboembolism (PREVENT)
|
Phase 3 | |
| Completed |
NCT00000530 -
Raynaud's Treatment Study (RTS)
|
Phase 3 | |
| Completed |
NCT00000539 -
Arterial Disease Multifactorial Intervention Trial (ADMIT)
|
Phase 3 | |
| Completed |
NCT00000479 -
Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
|
Phase 3 | |
| Completed |
NCT00000474 -
Prevention and Treatment of Hypertension Study (PATHS)
|
Phase 3 | |
| Completed |
NCT00000528 -
Trials of Hypertension Prevention (TOHP)
|
Phase 3 | |
| Completed |
NCT00000509 -
Potassium and Sodium to Control Blood Pressure in Hypertensives
|
Phase 3 | |
| Completed |
NCT00000501 -
Hypertension Prevention Trial (HPT) Feasibility Study
|
Phase 2 | |
| Completed |
NCT00000499 -
Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)
|
Phase 2 |